Overcoming deficiencies in the early detection of endometrial cancer: evaluating exosomal proteins as novel biomarkers of disease

Ended Project Grant Awarded Last action

Award ID
W81XWH2210656
Recipient
Awarding agency
Obligated
$3,876,768

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Funding
  • $1,938,384.00 Federal
  • $1,938,384.00 Non-federal
Place of performance
Columbus, OH 43210, USA

Award details come from USAspending.gov.

About this award

The Department of the Army Medical Command awarded a $3.876 million Project Grant to The Ohio State University Office of Sponsored Programs on August 1, 2022 under the Military Medical Research and Development program (CFDA 12.420). The four-year project will evaluate exosomal proteins as novel biomarkers for the early detection of endometrial cancer.

The Ohio State University will lead the research effort to identify and validate exosomal protein biomarkers that could transform care for service members and the public through improved endometrial cancer screening. Inova Health Care Services will serve as a sub-awardee, providing biospecimens and clinical data from its tissue bank and expertise through its principal investigator, Dr. Larry Maxwell. Inova will also assist in liquid chromatography-tandem mass spectrometry analysis of relevant biomarker cohorts. The research has the potential to improve medical solutions for battlefield health as well as investigate innovative screening methods.

Quick answers

Who received award W81XWH2210656?

W81XWH2210656 was awarded to The Ohio State University by Medical Command (Department of the Army) on August 1, 2022.

How much is award W81XWH2210656 worth?

$3,876,768 has been obligated on W81XWH2210656: $1,938,384 in federal funding and $1,938,384 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award